Registry for Patients With X-Linked Hypophosphatemia
An International, Multicentre, Prospective, Non-interventional Observational Registry for Patients With X-Linked Hypophosphatemia (XLH)
Kyowa Kirin Pharmaceutical Development Ltd
1,343 participants
Sep 12, 2017
OBSERVATIONAL
Conditions
Summary
This is an international, multicentre, prospective, non-interventional, observational Registry of patients with X-Linked hypophosphatemia (XLH). The main objective of this XLH Registry is to collect data to characterise the treatment, progression and long-term outcomes of XLH in both adult and paediatric settings.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(118)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03193476